Back to MW MARSHALL WACE, LLP

NMRANMRA
9 quarters

Position history for MWMARSHALL WACE, LLP's holdings in NEUMORA THERAPEUTICS INC.

Yes. Marshall Wace holds 904,458 shares of NMRA (Neumora Therapeutics), worth $1.5M, as of its Q2 2026 13F filing. It reduced the position by 290,852 shares (-24.3%) from Q1 2026. Marshall Wace has held NMRA since Q4 2025, across 3 quarterly 13F filings.

Current Value

$1.5M

Current Shares

904,458

Total Value Change

-$2.1M

Total Shares Change

+648,046

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
904,458
-24.3%
$1.5M0.0%$1.70
0
2026-Q1
Increased
1.2M
+104.8%
$2.3M0.0%$3.06
42
2025-Q4
New
583,758
-
$1M0.0%$1.77
35
2025-Q3
Exited
0
-100.0%
$00.0%$1.76
0
2025-Q2
New
250,490
-
$182,8580.0%$0.76
31
2024-Q3
Exited
0
-100.0%
$00.0%$12.92
0
2024-Q2
New
134,545
-
$1.3M0.0%$9.83
35
2023-Q4
Exited
0
-100.0%
$00.0%$17.05
0
2023-Q3
New
256,412
-
$3.6M0.0%$14.11
37

Other major holders of NMRA: SOFTBANK GROUP CORP., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used